News for Johnson & Johnson (JNJ)

Gilead Sciences and Johnson & Johnson are part of the Zacks Investment Ideas article.

Get the latest stock market news: Stock movers, top-performing sectors, and popular stock activity. Stay ahead with a quick and comprehensive market rundown.

PR NewswireSPRING HOUSE, Pa., March 10, 2025 Topline results also show investigational targeted oral peptide icotrokinra achieved clinical remission rates

Johnson & Johnson said that its mid-stage study of icotrokinra, for the treatment of moderate to severe active ulcerative colitis, met main goal.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

What were their toughest transitions? Where did they go for support? International MBAs studying abroad in the United Kingdom share their advice

Don't close your eyes. Just keep looking. Maybe the cavalry is on the horizon, it's just the rhetorical smoke that's blocking it.

We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend ...

H3X is building integrated motor drives from 30 kilowatts to three megawatts that are claimed to be unparalleled in performance in terms of specific power [kW/kg] and efficiency In 2023, Lockheed…

It was during this tumultuous time, Johnson & Johnson founder Robert Wood Johnson was on a train to Colorado for vacation. During that journey he met with the Denver & Rio Grande Railway’s chief…

Protagonist Therapeutics Inc (PTGX) has released new data from its Phase 3 clinical program for icotrokinra, an investigational oral peptide targeting the IL-23

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICO

Volatility is surging, with the VIX "fear" index climbing to its highest level so far in 2025 as of March 3. Investors have been spooked by an inverted yield cu...

We recently published a list of Jim Cramer Discusses These 13 Stocks & Criticizes Billionaires.

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to lead R&D in obesity drugs. Read more here.

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising for long-term investors.

Uncertainty socked the U.S. stock market in February, short-circuiting an early-year rally and saddling fund investors with losses.

Johnson & Johnson (JNJ) stock in focus as company halts Phase 3 depression therapy trials for aticaprant over efficacy concerns. Read more here.